Literature DB >> 17507182

Functional analysis on the 5'-flanking region of human FXR gene in HepG2 cells.

Guiyu Lou1, Yuping Li, Bin Chen, Min Chen, Jian Chen, Rongxia Liao, Yan Zhang, Yuangzhon Wang, Dujin Zhou.   

Abstract

The farnesoid X receptor (FXR) is a bile acid (BA)-activated nuclear receptor that plays a major role in the regulation of BA and lipid metabolism. Although modulation of FXR expression has been reported, the mechanisms underlying the regulation of human FXR are yet unclear. Functional assays showed that the -150/+29 nucleotides region from the first nucleotide at the Exon I is the minimal promoter of the human FXR gene by the technique of serial deletion and point mutants of the 5'-flanking region. Chromatin immunoprecipitation analysis and electrophoretic mobility shift assay revealed that hepatic nuclear factor 1alpha (HNF1alpha) interacted with the region. Co-transfection of the promoter with HNF1alpha expression vectors enhanced promoter activity of FXR gene. Over-expression of HNF1alpha up-regulated FXR expression in HepG2 cells. These data indicate that (a) the identified HNF1alpha binding site serves as a positive regulatory sequence, (b) the binding site is functionally active both in vivo and in vitro, and (c) the transcription factor HNF1alpha that binds to this site plays an important role in the regulation of human FXR promoter activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507182     DOI: 10.1016/j.gene.2007.04.011

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression.

Authors:  Nian Liu; Zhipeng Meng; Guiyu Lou; Weiping Zhou; Xiaoqiong Wang; Yunfeng Zhang; Lisheng Zhang; Xiyong Liu; Yun Yen; Lily Lai; Barry M Forman; Zhonggao Xu; Rongzhen Xu; Wendong Huang
Journal:  Mol Endocrinol       Date:  2012-04-02

2.  Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O.

Authors:  Madalina Raducu; Jonathan Baets; Oihane Fano; Rudy Van Coster; Jesús Cruces
Journal:  Eur J Hum Genet       Date:  2012-03-14       Impact factor: 4.246

3.  Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells.

Authors:  Bin Chen; Yuanzhong Wang; Susan E Kane; Shiuan Chen
Journal:  J Mol Endocrinol       Date:  2008-09-03       Impact factor: 5.098

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.